Lobbying registrant · LD-2 disclosures
Glenmark Pharmaceuticals USA
New Jersey
30 filings · 1 client · 1 lobbyist registered · 2017–2024 · latest filed Sept 24, 2024
Fees billed to clients
$0
never billed a fee — files for itself
Its own lobbying spend
$4.9M
filed on its own behalf
Clients represented
1
1 lobbyist registered
Note · At least one filing discloses a foreign entity with an interest in a client this registrant represents. Those disclosures are listed below.
Reported spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who they lobby for
This registrant files only on its own behalf — it has never reported a fee for representing anyone else.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee charged to a client.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR · 1 client
23 filings
$4.9M on those filings
Medicare/Medicaid
MMM · 1 client
19 filings
$4.2M on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Who does the lobbying
Every lobbyist named on this registrant's filings.
- Grant ErdelCovered position: Legislative Correspondent - Senator Bond Administrative Assistant - Representative Jo Ann Emerson Senior Policy Advisor - Representative Charles Bass25 filings1 client · through 2022
Covered positions · 1 of 1 lobbyists named on these filings disclosed a prior government post. A covered official position is the LD-2 field a lobbyist uses to report having held one; the text is reproduced exactly as filed.
Foreign interests disclosed
Every foreign entity named on this registrant's filings.
Glenmark Pharmaceuticals
India
2 filings
through 2017
What this discloses · An LD-2 reports foreign entities that hold an interest in, or contribute to, the client — so these are foreign interests behind the organizations this registrant files for, not owners of the registrant itself. Disclosure is a reporting requirement, not an allegation.
The filings
The 20 most recent of 30 filings. Every figure above is built from these records.
This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: glenmark-pharmaceuticals-usa.